Related Experiment Video
Updated: Feb 15, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Expression of gremlin1 in gastric cancer and its clinical significance
Yoichi Yamasaki1, Sumiya Ishigami2, Takaaki Arigami1
1Department of Digestive Surgery, Breast and Thyroid Surgery, Kagoshima University School of Medicine, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.
Abstract:
As an antagonist of bone morphogenetic proteins (BMPs), 2, 4 and 7, gremlin1 plays a role in regulating organogenesis, tissue differentiation and angiogenesis. However, there is little information regarding gremlin1 in gastrointestinal cancer. We attempted to clarify how gremlin1 expression affects the clinical features and biological properties of gastric cancer. A total of 232 gastric cancer patients who received R0 gastrectomy at Kagoshima University Hospital were enrolled. Gremlin1 expression in gastric cancer was detected by immunohistochemical and western blotting methods. Correlations between clinicopathological parameters and gremlin1 expression were analyzed. Gremlin1 was identified in the cytoplasm and nucleus of all gastric cancer cell lines and some regions of surgical specimens of gastric cancer. One hundred and seventeen of the 232 patients (50.4%) were classified as gremlin1-positive based on gremlin1 expression. Gremlin1 positivity was correlated with shallower tumor depth, smaller tumor size, less nodal involvement and vessel invasion (p < 0.05). The 5-year survival rate of the gremlin1-positive group was 81%, which was significantly higher than the gremlin1-negative group (p < 0.01). Multivariate analysis revealed that gremlin1 was not selected as an independent prognostic marker. Gremlin1 expression in gastric cancer may be a useful prognostic marker that is involved with the BMP signaling pathway. Furthermore, gremlin1 may have clinical use as a diagnostic and treatment tool.
Insights
Gremlin1 expression in gastric cancer correlates with better prognosis and less aggressive features. This finding suggests gremlin1 may serve as a valuable diagnostic and therapeutic tool for stomach cancer.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Gremlin1 antagonizes bone morphogenetic proteins (BMPs), influencing organogenesis and tissue differentiation.
- Its role in gastrointestinal cancer, particularly gastric cancer, remains largely unexplored.
Purpose of the Study:
- To investigate the correlation between gremlin1 expression and the clinical features and biological properties of gastric cancer.
- To assess the prognostic significance of gremlin1 in gastric cancer patients.
Main Methods:
- Immunohistochemistry and western blotting were used to detect gremlin1 expression in 232 gastric cancer patients.
- Clinicopathological parameters were analyzed for correlations with gremlin1 expression levels.
Main Results:
- Gremlin1 was detected in gastric cancer tissues and cell lines.
- Gremlin1 positivity was associated with shallower tumor depth, smaller tumor size, and reduced nodal and vessel invasion.
- The 5-year survival rate was significantly higher in gremlin1-positive patients (81%) compared to gremlin1-negative patients.
Conclusions:
- Gremlin1 expression in gastric cancer is linked to favorable clinicopathological features and improved survival.
- While not an independent prognostic marker in multivariate analysis, gremlin1 shows potential as a prognostic indicator.
- Gremlin1 may have future clinical applications in gastric cancer diagnosis and treatment, potentially through its involvement in the BMP signaling pathway.
Related Concept Videos
Statistical Significance
Significance of Center of Mass
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Gastric Emptying

